Tag
Sudarshan Pharma Industries Limited
4 articles
Sudarshan Pharma Incorporates US Wholly-Owned Subsidiary
Sudarshan Pharma incorporated Sudarshan Industries Inc. in Delaware, USA on June 5, 2026 as a wholly-owned subsidiary.
The company subscribed to 100 million shares at $0.00001 par value for a total in
Sudarshan Pharma Warrants Committee Meeting on June 11
• Sudarshan Pharma scheduled a Warrants Committee meeting for June 11, 2026.
• The committee will consider approving conversion of warrants into equity shares.
• This is a regulatory disclosure pursua
Sudarshan Pharma Promoter Releases 20 Lakh Share Pledge
Sudarshan Pharma promoter Hemal Mehta released a pledge on 20 lakh shares, representing 0.83% of total capital.
The release was executed on June 3, 2026, and disclosed to BSE under SEBI Takeover Regul
Sudarshan Pharma Audited FY2026 Results
Discloses audited standalone and consolidated financial results for the half-year and full year ended 31st March 2026, submitted to BSE in response to a query on discrepancies.
Reports standalone net